Orkla ASA — AGM Information 2015

Jan 15, 2015

Key figures

Summary of Consolidated Income Statement	Financial year
all num bers in SEK million	2013	2012	2011
Net sales	1.984.1	1,929.6	2,065.7
Operating Profit	157.2	147.5	205.1
Profit before taxes	37.7	204	77 9
Profit for the period	22 7	37.6	75.7

Summary of Consolidated Balance Sheet	Financial year
all num bers in SEK million	2013	2012	2011
Assets
Non-current assets	1,768.7	1,765.6	1,763.7
Current assets	733.1	727.2	754.9
Total assets	2,501.8	2,492.7	2,518.6
Equity and liabilities
Equity	308.0	296.0	2678
Non-current liabilities	1,790.9	1,776.9	1,829.6
Current liabilities	402.9	419.8	421.2
Total equity and liabilities	2,501.8	2.492.7	2.518.6

There are no significant assets or obligations that are not disclosed on the Group's balance sheet.

Board of directors and management

The board of directors of Cederroth Intressenter AB ("Cederroth") consists of Conny Karlsson (chair), Göran Barsby, Mikael Hellberg, Jacqueline Hoogerbrugge, Thomas Thomsen and Lars Verneholt. Harold Kaiser is deputy board member.

The management of Cederroth consists of Mikael Nordin (CEO), Ulf Spolander (CFO), Sara Brandt (EVP Nordic), Maria Lundman Hedberg (EVP Wound Care), Ola Carlstein (Director of Group Operations), Rafal Szczepkowski (MD Poland) and Camilla Hedenfelt (HR Director).

Agreements in connection with the transaction

There are no, nor are there expected to be any, agreements made that would benefit board members or key personnel at Orkla as a result of the transaction. The same applies to the board members of Cederroth. Plans are being made to offer incentive schemes to certain key employees of Cederroth on market terms.